- Home
- KLTR vs MREO Comparison
KLTR vs MREO Comparison
Compare KLTR & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- MREO
- Stock Information
- Founded
- KLTR 2006
- MREO 2015
- Country
- KLTR United States
- MREO United Kingdom
- Employees
- KLTR N/A
- MREO N/A
- Industry
- KLTR EDP Services
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- KLTR Technology
- MREO Health Care
- Exchange
- KLTR Nasdaq
- MREO Nasdaq
- Market Cap
- KLTR 302.6M
- MREO 326.1M
- IPO Year
- KLTR 2021
- MREO N/A
- Fundamental
- Price
- KLTR $1.51
- MREO $1.97
- Analyst Decision
- KLTR Buy
- MREO Strong Buy
- Analyst Count
- KLTR 3
- MREO 5
- Target Price
- KLTR $2.83
- MREO $7.40
- AVG Volume (30 Days)
- KLTR 300.5K
- MREO 1.3M
- Earning Date
- KLTR 11-05-2025
- MREO 11-11-2025
- Dividend Yield
- KLTR N/A
- MREO N/A
- EPS Growth
- KLTR N/A
- MREO N/A
- EPS
- KLTR N/A
- MREO N/A
- Revenue
- KLTR $181,350,000.00
- MREO $500,000.00
- Revenue This Year
- KLTR $3.43
- MREO N/A
- Revenue Next Year
- KLTR $2.96
- MREO $72.16
- P/E Ratio
- KLTR N/A
- MREO N/A
- Revenue Growth
- KLTR 2.56
- MREO N/A
- 52 Week Low
- KLTR $1.24
- MREO $1.47
- 52 Week High
- KLTR $2.82
- MREO $4.72
- Technical
- Relative Strength Index (RSI)
- KLTR 43.70
- MREO 57.79
- Support Level
- KLTR $1.36
- MREO $1.94
- Resistance Level
- KLTR $1.57
- MREO $2.12
- Average True Range (ATR)
- KLTR 0.09
- MREO 0.11
- MACD
- KLTR -0.01
- MREO 0.02
- Stochastic Oscillator
- KLTR 32.63
- MREO 62.65
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).